INFORMATION:
For media enquiries contact Emily Head in the Cancer Research UK press office on 020 3469 6189 or, out of hours, on 07050 264 059.
Notes to editor:
The study has been part-funded by the European Research Council, through an Advanced Grant, worth over £1.7 million.
* von Karstedt et al. Cancer cell-autonomous TRAIL-R signalling promotes KRAS-driven cancer progression, invasion and metastasis. Cancer Cell. DOI: 10.1016/j.ccell.2015.02.014.
** Pancreatic ductal adenocarcinoma.
About the European Research Council
Set up in 2007 by the EU, the European Research Council is the first European funding organisation for frontier research. The ERC operates according to an 'investigator-driven', or 'bottom-up', approach, allowing researchers to identify new opportunities in any field of research, without thematic priorities. Every year, it selects and funds the very best, creative researchers of any nationality and age to run five-year projects based in Europe. Since its launch, the ERC has funded over 4,500 researchers. Under Horizon 2020, the new EU research programme (2014-2020), the ERC has a budget of over €13 billion.
erc.europa.eu
About UCL (University College London)
Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. We are among the world's top universities, as reflected by performance in a range of international rankings and tables. UCL currently has over 35,000 students from 150 countries and more than 11,000 staff. Our annual income is more than £1 billion.
http://www.ucl.ac.uk | Follow us on Twitter @uclnews | Watch our YouTube channel YouTube.com/UCLTV
About the UCL Cancer Institute
UCL Cancer Institute, London, is the hub for cancer research at University College London (UCL), one of the world's leading universities. The UCL Cancer Institute draws together over 300 researchers and clinicians working together to translate research discoveries into new strategies to prevent, diagnose and treat cancer.
The UCL Cancer Institute is affiliated with leading teaching and specialist hospitals in central London, including University College Hospital London (UCLH), Royal Free Hospital and Great Ormond Street Hospital. The Institute is rapidly developing as one of the country's leading cancer research centres with a strong record of achievement and international reputation for clinical trials, research into childhood cancer and cancers affecting teenagers, haematological malignancies (including leukaemia and lymphoma), lung, liver, brain cancers and sarcoma.
The mission of the UCL Cancer Institute is to decrease the burden of cancer through laboratory and clinical research; develop excellence and place UCL as a major national and international hub for cancer research; and educate the next generation of cancer researchers and clinicians.
Visit http://www.ucl.ac.uk/cancer | Follow us on Twitter @uclcancer
About Cancer Research UK
Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.
Cancer Research UK's pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on every pound donated.
Cancer Research UK has been at the heart of the progress that has already seen survival rates in the UK double in the last forty years.
Today, 2 in 4 people survive cancer for at least 10 years. Cancer Research UK's ambition is to accelerate progress so that 3 in 4 people will survive cancer within the next 20 years.
Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured.
For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022 or visit http://www.cancerresearchuk.org. Follow us on Twitter and Facebook.
Body's cancer defences hijacked to make pancreatic and lung cancers more aggressive
2015-04-02
(Press-News.org) CANCER RESEARCH UK scientists have discovered that a vital self-destruct switch in cells is hijacked - making some pancreatic and non small cell lung cancers more aggressive, according to research published in Cancer Cell today (Thursday)*.
The team, from the Cancer Research UK Centre at the UCL (University College London) Cancer Institute, found that mutations in the KRAS gene interferes with protective self-destruct switches, known as TRAIL receptors, which usually help to kill potentially cancerous cells.
The research, carried out in cancer cells and mice, shows that in cancers with faulty versions of the KRAS gene these TRAIL receptors actually help the cancer cells to grow and spread to new areas in the body.
These KRAS faults occur in 95 per cent of pancreatic cancers** and 30 per cent of non small cell lung cancers.
Professor Henning Walczak, lead researcher of the study and scientific director of the Cancer Research UK-UCL Centre, said: "Our research has unveiled a new strategy used by some pancreatic and non small cell lung cancers to overcome our body's natural defences against cancer. By understanding the faults in these cancers we think we can develop more tailored treatments, which could one day provide urgently-needed options for patients with these types of pancreatic and non small cell lung cancers."
Each year in Great Britain 32,500 people are diagnosed with non small cell lung cancer and around 8,600 people are diagnosed with pancreatic cancer. Survival for these cancers has not shown much improvement for 40 years.
Nell Barrie, senior science information manager at Cancer Research UK, said: "Sadly survival from pancreatic and lung cancers remains far too low, partly because these cancers are very difficult to treat once they have spread.
"We urgently need better treatments, so it's vital to delve deeper into the molecular workings of these cancers to find ways to combat them. This research may one day help us find a way to block cancer spread, which would be a vital step to save more lives."
ELSE PRESS RELEASES FROM THIS DATE:
Study finds new genetic clues to pediatric seizure disorders
2015-04-02
Researchers have identified a new genetic mutation at the heart of a severe and potentially deadly seizure disorder found in infants and young children. The finding, which was reported today in the journal American Journal of Human Genetics, may help scientists unravel the complex biological mechanism behind these diseases.
"These findings allow us to open up what was, up to this point, a 'black box' and more fully understand the biological pathways associated with these disorders and why some individuals do not respond to treatment," said Alex Paciorkowski, M.D., an ...
Rice U. study: Algae from wastewater solves 2 problems
2015-04-02
In one of the first studies to examine the potential for using municipal wastewater as a feedstock for algae-based biofuels, Rice University scientists found they could easily grow high-value strains of oil-rich algae while simultaneously removing more than 90 percent of nitrates and more than 50 percent of phosphorous from wastewater.
The findings, which are based on a five-month study at a wastewater treatment facility in Houston, are available online in the journal Algae.
"Biofuels were the hot topic in algaculture five years ago, but interest cooled as the algae ...
How to crowdsource the world for emergency medicine
2015-04-02
WASHINGTON --Two new studies, published online Tuesday in Annals of Emergency Medicine, illustrate the power of social media and the Internet to promote scholarly dialogue around the world and the importance of establishing criteria for what constitutes high-quality blogs and podcasts ("Global Emergency Medicine Journal Club: A Social Media Discussion About the ADJUST-PE Trial" and "Emergency Medicine and Critical Care Blogs and Podcasts: Establishing an International Consensus on Quality").
"Our Global Emergency Medicine Journal Club creates a virtual space to allow ...
Circulation of highly pathogenic avian flu in North American birds
2015-04-02
Highly pathogenic avian influenza (HPAI) H5 viruses of Eurasian origin continue to circulate and evolve in North American wild birds.
The U.S. Geological Survey and U.S. Department of Agriculture published the genetic analysis of a mixed-origin HPAI H5N1 avian flu virus in the journal Genome Announcements today. This novel virus was discovered in a green-winged teal in Washington State that was sampled at the end of 2014. It is a mixed-origin virus containing genes from the Eurasian HPAI H5N8 and genes from North American low pathogenic avian influenza from wild birds. ...
Black holes don't erase information, scientists say
2015-04-02
BUFFALO, N.Y. - Shred a document, and you can piece it back together. Burn a book, and you could theoretically do the same. But send information into a black hole, and it's lost forever.
That's what some physicists have argued for years: That black holes are the ultimate vaults, entities that suck in information and then evaporate without leaving behind any clues as to what they once contained.
But new research shows that this perspective may not be correct.
"According to our work, information isn't lost once it enters a black hole," says Dejan Stojkovic, PhD, associate ...
Potential chemoresistance after consuming fatty acid in fish, fish oil
2015-04-02
Researchers found that consuming the fish herring and mackerel, as well as three kinds of fish oils, raised blood levels of the fatty acid 16:4(n-3), which experiments in mice suggest may induce resistance to chemotherapy used to treat cancer, according to a study published online by JAMA Oncology.
Patients with cancer often adopt lifestyle changes and those changes often include the use of supplements. But there is growing concern about the use of supplements while taking anticancer drugs and the possible effect on treatment outcomes, according to the study background.
Emile ...
One test can predict which kids will become nearsighted
2015-04-02
COLUMBUS, Ohio - A study of 4,500 U.S. children over 20 years has identified a single test that can predict which kids will become nearsighted by the eighth grade: a measure of their current refractive error.
The refractive error, or eyeglasses prescription, results from mismatches in the size and optical power of the eye that lead to blurry vision.
The study also counters the notion that near work such as frequent reading or sitting too close to the television can bring on myopia, or nearsightedness.
"Near work has been thought to be a cause of myopia, or at least ...
Hubble finds ghosts of quasars past
2015-04-02
The NASA/ESA Hubble Space Telescope has imaged a set of enigmatic quasar ghosts -- ethereal green objects which mark the graves of these objects that flickered to life and then faded. The eight unusual looped structures orbit their host galaxies and glow in a bright and eerie goblin-green hue. They offer new insights into the turbulent pasts of these galaxies.
The ethereal wisps in these images were illuminated, perhaps briefly, by a blast of radiation from a quasar -- a very luminous and compact region that surrounds a supermassive black hole at the centre of a galaxy. ...
Statistical analysis reveals Mexican drug war increased homicide rates
2015-04-02
A new statistical analysis suggests that, in the short term, the Mexican government's war against drugs increased the average murder rate in regions subjected to military-style interventions.
The study--"Did the Military Interventions in the Mexican Drug War Increase Violence?"--was conducted by Valeria Espinosa, a quantitative analyst at Google and a 2014 doctoral graduate of Harvard University's statistics department, and Donald B. Rubin, Harvard University John L. Loeb Professor of Statistics.
The paper is published on the website of The American Statistician, a ...
Beta secretase inhibitors to treat Alzheimer's disease
2015-04-02
Philadelphia, PA, April 2, 2015 - With each new amyloid-targeting treatment for Alzheimer's disease that has been developed, there has been a corresponding concern. For example, antibodies targeting amyloid-β peptide (Aβ) produce inflammation in the brain in some patients. Gamma secretase inhibitors tend to produce adverse effects by interacting with Notch, an important pathway for cellular signaling.
Beta secretase 1 (BACE1) inhibitors are a new and promising target for Alzheimer's disease. Inhibiting BACE1 will limit the production of Aβ which, in turn, ...